Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06420427
Status:
RECRUITING
Last Update Posted:
2024-05-20
First Post:
2024-05-14
Brief Title:
Dynamic Monitoring of ctDNA and HPV DNA in Plasma for the Early Prediction of Recurrence After Cervical Cancer Surgery
Sponsor:
The Third Affiliated Hospital of Guangzhou Medical University
Organization:
The Third Affiliated Hospital of Guangzhou Medical University
Study Overview
Official Title:
Dynamic Monitoring of Circulating Tumor DNA ctDNA and HPV DNA in Plasma for the Early Prediction of Recurrence After Cervical Cancer SurgeryTreatment
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Assess the sensitivity specificity positive predictive value and negative predictive value of dynamic monitoring of circulating tumor DNA ctDNA combined with circulating HPV DNA cfHPV DNA for early prediction of recurrence in cervical cancer post-surgery or post-treatment and compare its advantages and disadvantages with existing diagnostic methods
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None